Valneva SE - ADR

NASDAQ:VALN  
27.85
+0.59 (+2.16%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.39B
Current PEN/A
Forward PE N/A
2yr Forward PE 6.81
See more stats
Estimates Current Quarter
Revenue$28.43 Million
Adjusted EPS-$0.90
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Valneva SE - ADR Stock, NASDAQ:VALN

Campus Bio-Ouest, 6, rue Alain Bombard, Saint-Herblain, Grand Est 44800
Phone: +33.2.28.07.37.10
Number of Employees:

Description

Valneva SE is a biotech company. The firm engages in the development, production and marketing of vaccine and preventive medicine. It operates through the following segments: Commercialized Vaccines, Technologies and Services and Vaccine Candidates. The Commercialized Vaccines segment includes currently marketed vaccines of the group such as JEV and DUKORAL. The Technologies and Services segment regroups services and inventions in commercialization stage. The Vaccine Candidates segment consists of proprietary research and development programs aiming to generate new approvable products. The company was founded on April 7, 1999 and is headquartered in Saint-Herblain, France.